Cara Therapeutics Inc (CARA)

17.05
0.10 0.58
NASDAQ : Health Care
Prev Close 17.15
Open 17.19
Day Low/High 17.00 / 17.50
52 Wk Low/High 4.26 / 23.61
Volume 627.59K
Avg Volume 2.15M
Exchange NASDAQ
Shares Outstanding 32.51M
Market Cap 571.81M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

Jim Cramer is bullish on Six Flags and Cara Therapeutics, but he's bearish on General Motors and Pandora.

Ignore That Man in the White House? Cramer's 'Mad Money' Recap (Wednesday 5/10/17)

Ignore That Man in the White House? Cramer's 'Mad Money' Recap (Wednesday 5/10/17)

Jim Cramer says he's amazed that stocks -- and gold, even -- are just yawning at Trump's move to fire FBI Director Comey.

Berkshire Hathaway, Southwest, Alaska Air: 'Mad Money' Lightning Round

Berkshire Hathaway, Southwest, Alaska Air: 'Mad Money' Lightning Round

Jim Cramer says he respects Buffett's judgment. Cramer's also bullish on some airline stocks.

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety Of I.V. CR845

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety Of I.V. CR845

- I.V. CR845 statistically equivalent to placebo across all measures of respiratory safety -

Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout

Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout

Incyte has been doing great, locking in deals with Bristol-Myers and Merck. It's worth a lot more in a takeover situation, Cramer said.

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Jim Cramer stresses discipline here because, he says, a frothy market can quickly turn on investors.

5 Stocks Insiders Are Loading Up On

5 Stocks Insiders Are Loading Up On

Insiders at Tesla, Ford and three other companies have been scooping up shares of their own stock lately.

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

First Week Of November 17th Options Trading For Cara Therapeutics (CARA)

First Week Of November 17th Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options become available this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Cara Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results

Cara Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results

- Conference call today at 4:30 p.m. ET -

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

Market Action Is Boring but Necessary

Market Action Is Boring but Necessary

After yesterday's surprise pullback, this is the sort of consolidation we need.

Market Taking a Break, but Probably Not for Long

Market Taking a Break, but Probably Not for Long

Today is more about stock picking.

Why Cara Therapeutics Is Up, Trevena Down

Why Cara Therapeutics Is Up, Trevena Down

Readers want to know what to do with the two biotech names, which are headed in opposite directions.

First Week of April 21st Options Trading For Cara Therapeutics

First Week of April 21st Options Trading For Cara Therapeutics

Investors in Cara Therapeutics Inc saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CARA options chain for the new April 21st contracts and identified one put and one call contract of particular interest.